Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Pharma, Inc. | 165,993 | reported | 20 Jun 2025 | tx 17+750,453−159,404 |
| Coherus Oncology, Inc. | 112,000 | reported | 12 Jun 2025 | tx 10+271,997 |
| Eidos Therapeutics, Inc. | 0 | reported | 26 Jan 2021 | tx 22+25,205,637−16,371,288 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 6,589 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 8,425 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Coherus Oncology, Inc. | 112,000 | 0.00 USD | deriv |
| 30 Dec 2024 | EXERCISE | BridgeBio Pharma, Inc. | 79,702 | 10.99 USD | |
| 30 Dec 2024 | EXERCISE | BridgeBio Pharma, Inc. | 39,851 | 16.68 USD | |
| 30 Dec 2024 | EXERCISE | BridgeBio Pharma, Inc. | 39,851 | 26.21 USD | |
| 30 Dec 2024 | EXERCISE | BridgeBio Pharma, Inc. | 79,702 | 0.00 USD | deriv |
| 30 Dec 2024 | EXERCISE | BridgeBio Pharma, Inc. | 39,851 | 0.00 USD | deriv |
| 30 Dec 2024 | EXERCISE | BridgeBio Pharma, Inc. | 39,851 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | BridgeBio Pharma, Inc. | 26,014 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | BridgeBio Pharma, Inc. | 51,501 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | BridgeBio Pharma, Inc. | 104,921 | 0.00 USD | deriv |
| 17 Jun 2021 | GRANT_AWARD | BridgeBio Pharma, Inc. | 38,895 | 0.00 USD | deriv |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 43,056 | — | deriv |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 21,528 | — | deriv |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 21,528 | — | deriv |
| 26 Jan 2021 | GRANT_AWARD | BridgeBio Pharma, Inc. | 39,851 | 0.00 USD | deriv |
| 26 Jan 2021 | GRANT_AWARD | BridgeBio Pharma, Inc. | 79,702 | 0.00 USD | deriv |
| 26 Jan 2021 | GRANT_AWARD | BridgeBio Pharma, Inc. | 39,851 | 0.00 USD | deriv |
| 02 Jun 2020 | GRANT_AWARD | BridgeBio Pharma, Inc. | 112,422 | 0.00 USD | deriv |
| 27 May 2020 | GRANT_AWARD | Eidos Therapeutics, Inc. | 21,528 | 0.00 USD | deriv |
| 10 Jan 2020 | GRANT_AWARD | Coherus Oncology, Inc. | 20,000 | 0.00 USD | deriv |
| 12 Dec 2019 | GRANT_AWARD | BridgeBio Pharma, Inc. | 82,878 | 0.00 USD | deriv |
| 03 Jul 2019 | PURCHASE | Eidos Therapeutics, Inc. | 882,353 | 29.90 USD | |
| 12 Jun 2019 | GRANT_AWARD | Eidos Therapeutics, Inc. | 21,528 | 0.00 USD | deriv |